---
$id: https://graph.org.ai/products/commodity/51393407
$type: Product
source: UNSPSC
code: "51393407"
title: "Tazifylline"
class: "51393400"
classTitle: "Sympathomimetic or adrenergic xanthines"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tazifylline

**UNSPSC Code**: 51393407
**Class**: [Sympathomimetic or adrenergic xanthines](Sympathomimetic or adrenergic xanthines.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a bronchodilator with the molecular formula C23H32N6O3S.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F45OX6FZWP, chemically known as 7-[2-hydroxy-3-[4-(3-phenylsulfanylpropyl)piperazin-1-yl]propyl]-1,3-dimethylpurine-2,6-dione but generally known as tazifylline, which bears US NIH Compound Identifier 54424. Most nations schedule tazifylline under HS 29395900 and SITC 54145. As of Q4 2014, TAZIFYLLINE remains the US FDA Preferred Term for this commodity. Tazifylline bears US NLM identifiers UMLS ID C0075869 and NCI Concept Code C96196. SMILES: CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CN3CCN(CC3)CCCSC4=CC=CC=C4)O.

